U.S. High Court Won’t Decide ‘Clear Evidence’ In $63M Children’s Motrin Verdict

(January 19, 2016, 1:40 PM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 19 denied a petition by Johnson & Johnson and a subsidiary to decide if denial of a citizen petition constitutes “clear evidence” that the Food and Drug Administration rejected a stronger warning about the risk of toxic epidermal necrolysis (TEN) in over-the-counter drugs such as Children’s Motrin (Johnson & Johnson, et al. v. Lisa Reckis, et al., No. 15-449, U.S. Sup.).

The denial of the petition for a writ of certiorari preserves a $63 million state jury...
To view the full article, register now.